NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NEI E-042-2020-0-US-01 MOUSE EMBRYO CULTURE IMAGING CHAMBER AND METHODS THEREOF US 62/968,474 Abandoned
NIAID E-005-2017-0-US-06 HEPATITIS B NANOPARTICLE-BASED VACCINE FOR INFLUENZA VIRUS US National Stage 16/635,240 11535651 Issued PDF
NIAID E-145-2015-3-US-14 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV US CON 16/777,559 10869856 Issued PDF
NIAID E-089-2019-0-PCT-02 SIRPalpha Expression On T Cells Is A Biomarker For Functional T Cells During Exhaustion PCT PCT PCT/US2020/015905 Expired
NIBIB E-047-2019-0-PCT-02 Development Of Dual Albumin Binder For Long-lasting Therapeutic Peptide Delivery PCT PCT PCT/US2020/015818 Expired
NIDCR E-190-2015-0-US-05 METHOD AND DEVICE FOR DETECTING ANTIGEN-SPECIFIC ANTIBODIES IN A BIOLOGICAL FLUID SAMPLE BY USING NEODYMIUM MAGNETS US DIV 16/776,831 Abandoned
NIBIB E-047-2019-0-CN-03 CONJUGATES OF BIVALENT EVANS BLUE DYE DERIVATIVES AND METHODS OF USE CN National Stage 202080011696.1 Abandoned
NIBIB E-047-2019-0-HK-08 Development Of Dual Albumin Binder For Long-lasting Therapeutic Peptide Delivery HK EP 62022046553.3 Pending
NIBIB E-047-2019-0-EP-04 Development Of Dual Albumin Binder For Long-lasting Therapeutic Peptide Delivery EP National Stage 20708884.0 Abandoned
NIBIB E-047-2019-0-IL-05 CONJUGATES OF BIVALENT EVANS BLUE DYE DERIVATIVES AND METHODS OF USE IL National Stage 284898 Abandoned
NIBIB E-047-2019-0-SG-06 CONJUGATES OF BIVALENT EVANS BLUE DYE DERIVATIVES AND METHODS OF USE SG National Stage 11202108081P Abandoned
NCI E-183-2017-0-KR-10 Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains KR National Stage 10-2020-7002752 Issued
NCI E-195-2018-0-PCT-02 DETECTION OF BCL-2 FAMILY HETERODIMER COMPLEXES AND USE THEREOF PCT PCT PCT/US2020/015694 Expired
NCI E-193-2017-0-US-03 Ultrasound Sensitive Peptide Particles For Spatially Resolved Molecule Delivery US National Stage 16/634,679 12064514 Issued PDF
NIAID E-182-2020-0-US-01 CORONAVIRUS RNA VACCINES US 62/967,006 Abandoned
NIDCD E-029-2020-0-US-01 Use of Statins to Treat or Prevent Drug Induced Hearing Loss US 62/966,794 Abandoned
NCI E-014-2018-0-US-07 Compositions and Methods For Treating Cancer With Anti-CD22 Immunotherapy US DIV 16/773,379 11878052 Issued PDF
NIDCR E-186-2009-0-US-08 APOPTOTIC CELL-MEDIATED INDUCTION OF ANTIGEN SPECIFIC REGULATORY T-CELLS FOR THE THERAPY OF AUTOIMMUNE DISEASES IN ANIMALS AND HUMANS US CON 16/773,982 Abandoned
NIAID E-089-2002-1-EP-88 Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in The 3'-UTR of Dengue Types 1,2,3, And 4, or Antigenic Chimeric Dengue Viruses 1,2,3, And 4 EP DIV 20153909.5 Expired
NCI E-041-2020-0-US-01 RAB13 AND NET1 ANTISENSE OLIGONUCLEOTIDES TO TREAT METASTATIC CANCER US 62/966,204 Abandoned
NCI E-148-2011-0-US-38 ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III CHIMERIC ANTIGEN RECEPTORS AND USE OF SAME FOR THE TREATMENT OF CANCER US CON 16/751,643 11124580 Issued PDF
NCI E-217-2011-1-US-12 A NOVEL INTERFERON-(lambda)4 (IFNL-4) PROTEIN, RELATED NUCLEIC ACID MOLECULES, AND USES THEREOF US CON 16/752,105 Abandoned
NIAID E-154-2010-1-US-15 CHIMPANZEE ADENOVIRAL VECTOR-BASED FILOVIRUS VACCINES US CON 16/751,470 Abandoned
NIDCD E-004-2019-1-US-01 ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY US 62/965,506 Abandoned
NINDS E-208-2020-0-US-02 MOLECULES TARGETING SURVIVAL MOTOR NEURON 2 US ORD 16/750,531 Abandoned
NIAID E-158-2007-3-US-07 LIVE ATTENUATED VIRUS VACCINES FOR LA CROSSE VIRUS AND OTHER BUNYAVIRIDAE US CON 16/750,437 Abandoned
CC E-184-2012-0-US-02 IMAGEABLE EMBOLIC MICROSPHERE US CON 16/749,370 11672876 Issued PDF
NCI E-234-2014-1-JP-01 METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF JP DIV 2020-007980 Issued
NIAMS E-192-2017-0-EP-04 ANTIBODIES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF HEPATITIS B VIRUS INFECTION EP National Stage 18750051.7 Abandoned
NIAID E-103-2014-3-AU-13 Antibody Evolution Immunogens AU DIV 2020200453 Abandoned
NCI E-029-2019-0-TW-02 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION TW ORD 109102511 Pending
NCI E-039-2017-0-US-04 Phenyl Indole Allosteric Inhibitors Of P97 ATPase US DIV 16/748,654 11247985 Issued PDF
NCI E-029-2019-0-PCT-03 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION PCT PCT PCT/US2020/014382 Expired
NCI E-159-2019-0-US-01 HUMAN IMMUNOGENIC EPITOPES OF HEMO AND HHLA2 HUMAN ENDOGENOUS RETROVIRUSES (HERVs) US 62/963,872 Abandoned
NCI E-170-2019-0-US-01 HUMAN IMMUNOGENIC EPITOPES OF H, K, AND E HUMAN ENDOGENOUS RETROVIRUSES (HERVs) US 62/963,856 Abandoned
NCI E-169-2018-0-US-01 ARYL HYDANTOIN HETEROCYCLES AND METHODS OF USE US 62/963,959 Abandoned
NCI E-750-2013-0-US-19 METHOD FOR SUBTYPING LYMPHOMA TYPES BY MEANS OF EXPRESSION PROFILING US CON 16/746,347 11574704 Issued PDF
NEI E-008-2020-0-US-01 Gene Therapy For Treatment Of CRX-associated Retinopathies US 62/962,732 Abandoned
NHLBI E-070-2020-0-US-01 Isotopes Of Alpha Ketoglutarate And Related Compounds For Hyperpolarized MRI Imaging US 62/962,473 Abandoned
NHLBI E-069-2020-0-US-01 REAL-TIME MONITORING OF IN VIVO FREE RADICAL SCAVENGERS THROUGH HYPERPOLARIZED N-ACETYL CYSTEINE ISOTOPES US 62/961,855 Abandoned
NIAMS E-192-2017-0-IL-05 ANTIBODIES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF HEPATITIS B VIRUS INFECTION IL National Stage 272094 Abandoned
NCI E-028-2019-0-CN-04 HIGH AFFINITY MONOCLONAL ANTIBODIES TARGETING GLYPICAN-1 AND METHODS OF USE CN National Stage 202080010178.8 Issued
NIAMS E-192-2017-0-US-06 ANTIBODIES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF HEPATITIS B VIRUS INFECTION US National Stage 16/631,290 11827669 Issued PDF
NIAID E-060-2015-0-AU-16 Novel Multivalent Nanoparticle-Based Vaccines AU DIV 2020200303 Issued
NCI E-248-2016-0-US-05 PLASMA AUTOANTIBODY BIOMARKERS FOR BASAL LIKE BREAST CANCER US CON 16/743,906 11525831 Issued PDF
NCI E-028-2019-0-PCT-02 HIGH AFFINITY MONOCLONAL ANTIBODIES TARGETING GLYPICAN-1 AND METHODS OF USE PCT PCT PCT/US2020/013739 Expired
NIAID E-096-2019-0-PCT-02 HUMAN IMMUNODEFICIENCY VIRUS-SPECIFIC T CELL RECEPTORS PCT PCT PCT/US2020/013698 Expired
NCI E-028-2019-0-EP-05 HIGH AFFINITY MONOCLONAL ANTIBODIES TARGETING GLYPICAN-1 AND METHODS OF USE EP National Stage 20704743.2 Pending
NCI E-028-2019-0-AU-07 HIGH AFFINITY MONOCLONAL ANTIBODIES TARGETING GLYPICAN-1 AND METHODS OF USE AU National Stage 2020212534 Pending
NCI E-028-2019-0-CA-03 HIGH AFFINITY MONOCLONAL ANTIBODIES TARGETING GLYPICAN-1 AND METHODS OF USE CA National Stage 3125033 Pending